Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.21.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance, beginning at Sep. 30, 2019 $ 1,708 $ 36,201,758 $ (26,174,082) $ 10,029,384
Balance, beginning, shares at Sep. 30, 2019 17,077,873      
Stock-based compensation expense   5,194,784   5,194,784
Issuance of common stock, net of issuance costs $ 604 33,283,366   33,283,970
Issuance of common stock, net of issuance costs (in shares) 6,037,500      
Issuance of restricted stock for services (in shares) 6,980      
Exercise of stock options $ 3 171,027   $ 171,030
Exercise of stock options (in shares) 31,731     31,731
Net loss     (17,384,520) $ (17,384,520)
Balance, ending at Sep. 30, 2020 $ 2,315 74,850,935 (43,558,602) $ 31,294,648
Balance, ending, shares at Sep. 30, 2020 23,154,084     23,154,084
Stock-based compensation expense   3,696,384   $ 3,696,384
Issuance of common stock, net of issuance costs $ 920 42,615,456   42,616,376
Issuance of common stock, net of issuance costs (in shares) 9,200,000      
Issuance of common stock, Vera acquisition $ 31 1,759,189   1,759,220
Issuance of common stock, Vera acquisition (in shares) 308,635      
Issuance of restricted stock for services $ 1 (1)    
Issuance of restricted stock for services (in shares) 11,722      
Exercise of stock options $ 5 112,441   $ 112,446
Exercise of stock options (in shares) 47,052     47,052
Net loss     (25,409,301) $ (25,409,301)
Balance, ending at Sep. 30, 2021 $ 3,272 $ 123,034,404 $ (68,967,903) $ 54,069,773
Balance, ending, shares at Sep. 30, 2021 32,721,493     32,721,493